Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial. [electronic resource]
Producer: 20140401Description: 145 p. digitalISSN:- 1471-230X
- 2-Pyridinylmethylsulfinylbenzimidazoles -- therapeutic use
- Adult
- Aged
- Dyspepsia -- complications
- Esophagitis, Peptic -- drug therapy
- Female
- Gastroesophageal Reflux -- complications
- Humans
- Irritable Bowel Syndrome -- complications
- Male
- Middle Aged
- Pantoprazole
- Proton Pump Inhibitors -- therapeutic use
- Quality of Life
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.